To include your compound in the COVID-19 Resource Center, submit it here.

June 2 Financial Quick Takes: follow-ons for Allogene, Adaptimmune, plus DCVC Bio, Windtree and BMS

Allogene raises $550M follow-on
Allogene Therapeutics Inc. (NASDAQ:ALLO) raised $550 million late Monday through the sale of 11.7 million shares at $47, a 2% discount to its Friday close of $48.16,

Read the full 302 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers